Latest "Norwest Venture Partners" News Stories

13:16 EST 18th February 2019 | BioPortfolio

Here are the most relevant search results for "Norwest Venture Partners" found in our extensive news archives from over 250 global news sources.

More Information about Norwest Venture Partners on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Norwest Venture Partners for you to read. Along with our medical data and news we also list Norwest Venture Partners Clinical Trials, which are updated daily. BioPortfolio also has a large database of Norwest Venture Partners Companies for you to search.

Showing "Norwest Venture Partners" News Articles 1–25 of 14,000+


Impel NeuroPharma raises $67.5mm through Series D round

Impel NeuroPharma Inc. (intranasal treatments for CNS disorders) raised $67.5mm through a Series D round co-led by KKR and No...

Health Data Analytics Platform Health Catalyst Raises $100M, Reaches $1B Valuation

Health Catalyst, a Silicon Slopes, Utah-based provider of next-generation data, analytics and improvement, today announced it has raised $100 million in Series F equity and debt funding led by OrbiMed. The funding also included participation from Sequoia Capital, Norwest Venture Partners, Sands Capital Ventures, UPMC Enterprises, and Kaiser Permanente Ventures also contributed to the financi...

Series E brings $79mm to Nuvaira

Nuvaira Inc. (formerly Holaira; medical devices to treat obstructive lung diseases) raised $79mm in its Series E financing le...

Series B brings in $40mm for OncoResponse

OncoResponse Inc. (cancer immunotherapies) raised $40mm through its Series B round, which was led by RiverVest Venture Partne...

Kymera closes $65mm Series B round

Kymera Therapeutics Inc. (protein degradation-based drug discovery) raised $65mm through its Series B round. Bessemer Venture...

Series B lands $70mm for Akero

Just six months after its $65mm Series A financing, Akero Therapeutics Inc. has now raised $70mm through a Series B round led...

Magnolia Neurosciences launches with $31mm Series A round

With a $31mm Series A round, Accelerator Life Science Partners launched Magnolia Neurosciences Corp. (neuroprotective therape...

Millendo gets $49.5mm in financing concurrent with OvaScience merger closing

Concurrent with the closing of its reverse merger with OvaScience Inc., Millendo Therapeutics Inc. raised $49.5mm in a financ...

DMC Biotechnologies, Inc. Announces that Breakthrough Energy Ventures (BEV) has joined Capricorn Venture Partners in participating in their Series Seed Round

[Boulder, CO] October 3, 2018 – DMC (​​, an early-stage biotechnology company, announced today that Breakthrough Ventures Portfolio (BEV) has invested in the company’s Series Seed financing round. The round was led by Capricorn Venture Partners and supports the company’s […] The post DMC Biotechnologies, Inc. Announces that Breakthrough Energy Ventures (BEV) has join...

Nuvaira raises $79m financing to pursue COPD treatment

Nuvaira said the financing was led by U.S. Venture Partners, along with participation from Endeavour Vision, Qiming Venture Partners, Lightstone Ventures and Richard King Mellon Foundation. All of The post Nuvaira raises $79m financing to pursue COPD treatment appeared first on Compelo Medical Devices.

SVB Financial Group to Buy Venture Capital Firm Leerink, a Top 10 Underwriter for Biotech IPOs

Leerink Holdings is the Boston-based parent company of Leerink Partners. Leerink Partners is an investment bank focused on healthcare and life sciences.

Series B brings in $17mm for Cardialen

Cardialen Inc. (developing a low-energy implantable defibrillation therapy to gently restore normal heart rhythm) raised $17m...

Ribon raises $65mm in Series B round

Ribon Therapeutics Inc. (developing cancer therapies targeting cellular stress pathways) raised $65mm through its Series B ro...

RiverVest Venture Closes $184M Fund for Backing Healthcare Ventures

RiverVest Venture Partners, a St. Louis, MO-based venture capital firm with additional offices in San Diego, CA, and Cleveland, OH, has raised $184.4 million for its fourth fund dedicated to investing in healthcare companies. Since its launch, RiverVest has invested in 47 companies working to develop new drugs and medical devices. Nearly half of the […]

Directa Plus notified of big share transactions, with 19% of the graphene products developer changing hands

After the market close, Directa Plus reported that Indaco Venture Partners SGR, Italy’s largest independent venture capital asset management firm, had sold a holding of 8.06% in the group

ARCH Venture Partners looks to raise $600M in its 10th fund

The Chicago-based life sciences venture capital firm had previously raised $408.4 million for its ninth fund, in 2016. Others – including Pfizer and Taiho – have recently boosted their VC investment pools as well.

Inari Agriculture Harvests $40M to Ramp Up Gene Editing R&D

Less than one month after emerging from stealth, ag biotech startup Inari Agriculture is unveiling $40 million in capital to accelerate its work on gene-editing for crop breeding. The Series B round of financing for Cambridge, MA-based Inari adds Acre Venture Partners and Alexandria Venture Investments as investors. Inari was founded in 2016 by venture […]

Glilot Capital Partners Raises $110 Million for Its Third Fund

TEL AVIV, Israel, Oct. 15, 2018 /PRNewswire/ -- Glilot Capital Partners a Venture capital fund which invests in early-stage startups, has announced the closing of Read more...

Impel NeuroPharma Closes $67.5 Million Series D to Advance CNS Portfolio

Seattle-based Impel NeuroPharma closed on a Series D financing totaling $67.5 million. It was co-led by KKR and Northwest Venture Partners. Existing investors Vivo Capital, 5AM Ventures and venBio Partners also participated.

Qpex spins off from TMC, raises $33mm in Series A round

Qpex Biopharma Inc. spun off from the The Medicines Co. (TMC) raising $33mm in its Series A financing led by New Enterprise A...

BroadSpot Imaging gets $7.5mm in Series A funds; adds $8.6mm one year later

Ophthalmic device maker BroadSpot Imaging Corp. raised $7.5mm in its Series A financing led by Phoenix Venture Partners, whic...

Passage Bio launches with $115.5mm Series A round

Neuro-focused Passage Bio (AAV-delivered gene therapies) launched with a $115.5 million Series A round led by OrbiMed, Frazie...

Progressive Care Announces Pay-Off of Note to Chicago Venture Partners

MIAMI, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that it has paid off its convertible note to Chicago Venture Partners through an issuance of common stock. Progressive Care drew down a tranche against the Chicago Venture note in the amount of $636,304 on February 15, 2018. The issuance of 1...

Glasgow groups combine to launch genetic sequencing venture

Four groups based at the University of Glasgow are launching a new venture that will offer a ‘one-stop-shop’ for genetic sequencing for clinicians, researchers, industry partners and the NHS.

With 5 Gene Therapies Licensed from Penn, Passage Bio Launches with $115.5 Million Series A

Philadelphia-based Passage Bio launched with a Series A financing round worth $115.5 million. It was led by OrbiMed Advisors and joined by Frazier Healthcare Partners, Versant Ventures, New Leaf Venture Partners, Vivo Capital and Lilly Asia Ventures.

Quick Search


News Quicklinks